Bavarian Nordic to acquire Vivotif and Vaxchora travel vaccines from Emergent BioSolutions
Bavarian Nordic A/S will acquire two oral vaccines from Emergent BioSolutions for a total consideration of up to $380 million, to strengthen its position in ... Read More
Emergent BioSolutions begins phase 3 trial of CHIKV VLP vaccine candidate
Emergent BioSolutions said that it has dosed the first participant in a phase 3 clinical trial of CHIKV VLP — the company’s single-dose chikungunya vaccine ... Read More
Everything you need to know about Chikungunya Causes, Symptoms, Prevention and Treatment
Chikungunya is a viral fever transmitted by mosquitoes and spreads in humans by the bite of Aedes mosquitoes infected with Chikungunya virus. In this post ... Read More